Galenicum is a global pharmaceutical company whose mission is to improve quality and affordability of pharmaceutical products, food and nutritional supplements.

The company's activities span across multiple fields, including full spectrum B2B solutions (development, licensing and supply of pharmaceutical products), FDF CMO activities, sales and distribution of branded generics, sales of specialty dermatological products, and other adjacemt actvities.

​

Peninsula acquired a minority stake, while executing a capital increase in order to support the company's growth and the relative R&D efforts..